vTv Therapeutics
VTVT
19 hedge funds and large institutions have $1.04M invested in vTv Therapeutics in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 5 closing their positions.
1.12% less ownership
Funds ownership: 3.27% → 2.15% (-1.1%)
5% less funds holding
Funds holding: 20 → 19 (-1)
19% less capital invested
Capital invested by funds: $1.28M → $1.04M (-$241K)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$165K |
| 2 |
VF
Virtu Financial
New York
|
+$66.9K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
+$35.5K |
| 4 |
Goldman Sachs
New York
|
+$15.1K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$1.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$450K |
| 2 |
D.E. Shaw & Co
New York
|
-$64.8K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$38K |
| 4 |
Morgan Stanley
New York
|
-$13.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$12.9K |
VTVT Hedge Fund Activity: Q3 2019 in Review
19 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q3 2019, worth a combined $1.04M — down 19% from $1.28M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of VTVT and 4 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 2 added.
The largest buyer was Vanguard Group, adding an estimated $165K. The largest seller was Bank of America, cutting an estimated $450K.
- 19 institutional investors held vTv Therapeutics (VTVT) as of Q3 2019, down from 20 in Q2 2019.
- Funds reported $1.04M of vTv Therapeutics stock for Q3 2019, down 19% quarter-over-quarter.
- 4 funds opened new vTv Therapeutics positions in Q3 2019 and 5 closed out, a net change of -1 holder.
- The largest vTv Therapeutics buyer in Q3 2019 was Vanguard Group, an estimated $165K added.
- The largest vTv Therapeutics seller in Q3 2019 was Bank of America, an estimated $450K sold.
Based on aggregated 13F filings for Q3 2019.